Swine Flu (H1N1) vs. Ebola: Key Differences in Transmission, Severity, and Prevention
Two distinct viral diseases with vastly different epidemiology.
| Feature | Swine Flu (H1N1 Influenza) | Ebola Virus Disease |
|---|---|---|
| Virus family | Orthomyxoviridae (RNA) | Filoviridae (RNA) |
| Transmission | Respiratory droplets, aerosols, fomites | Direct contact with blood/body fluids |
| Contagiousness (R₀) | 1.2–1.6 (moderate) | 1.5–2.5 (lower, but high CFR) |
| Incubation | 1–4 days | 2–21 days |
| Typical symptoms | Fever, cough, sore throat, myalgia, fatigue | Fever, hemorrhage, vomiting, diarrhea, multi-organ failure |
| Case fatality rate | <0.1% (seasonal); ~0.5% (2009 pandemic) | 25–90% (outbreak-dependent) |
| Treatment | Oseltamivir, baloxavir (early); supportive | Supportive (fluids, electrolytes); mAb (Inmazeb, Ebanga); remdesivir |
| Vaccine | Annual quadrivalent flu vaccine (includes H1N1) | rVSV-ZEBOV (Ervebo) — ring vaccination |
| Pandemic potential | High (novel reassortment) | Low (requires direct contact) |
